key: cord-0786102-05x8e6he
authors: Zhang, Jia-Li; Li, Wen-Xiong; Li, Yue; Wong, Man-Sau; Wang, Yong-Jun; Zhang, Yan
title: Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism
date: 2020-08-05
journal: Phytomedicine
DOI: 10.1016/j.phymed.2020.153297
sha: 4c7839bd416ab1e4ee9b412856f057f1176fb008
doc_id: 786102
cord_uid: 05x8e6he

BACKGROUND: : Coronavirus disease-2019 (COVID-19) caused by infection with severe acute respiratory coronavirus-2 (SARS-CoV-2) has been spreading rapidly throughout China and in other countries since the end of 2019. The World Health Organization (WHO) has declared that the epidemic is a public health emergency of international concerns. The timely and appropriate measures for treating COVID-19 in China, which are inseparable from the contribution of traditional Chinese medicine (TCM), have won much praise of the world. PURPOSE: : This review aimed to summarize and discuss the essential role of TCM in protecting tissues from injuries associated with COVID-19, and accordingly to clarify the possible action mechanisms of TCM from the perspectives of anti-inflammatory, antioxidant and anti-apoptotic effects. METHODS: : Electronic databases such as Pubmed, ResearchGate, Science Direct, Web of Science, medRixv and Wiley were used to search scientific literatures. RESULTS: : The present review found that traditional Chinese herbs commonly used for the clinical treatment of organ damages caused by COVID-19, such as Scutellaria baicalensis, Salvia miltiorrhiza, and ginseng, could act on multiple signaling pathways involved in inflammation, oxidative stress and apoptosis. CONCLUSION: : TCM could protect COVID-19 patients from tissue injuries, a protection that might be, at least partially, attributed to the anti-inflammatory, antioxidant and anti-apoptotic effects of the TCM under investigation. This review provides evidence and support for clinical treatment and novel drug research using TCM.

A novel coronavirus infection in severe acute respiratory syndrome (SARS), named coronavirus disease 2019 by the World Health Organization (WHO) (World Health Organization, 2020a) , has been spreading rapidly to the whole of China and other countries since the end of 2019. Data from the WHO show that there are more than 83000 confirmed cases in 49 countries/regions, and 78959 confirmed cases, including 2791 deaths by February 28, 2020 in China (World Health Organization, 2020b . The total number of COVID-19 cases worldwide has already far outnumbered that of SARS in 2003, clearly showing the present epidemic is a major global threat to public health (Roosa et al., 2020) .

The source of infection and intermediate host of are not yet identified.

Studies found that severe acute respiratory coronavirus-2 (SARS-CoV-2) is 96% identical at the whole-genome level to the Chinese horseshoe bat coronavirus, thus, they conjectured that the Chinese horseshoe bat might be the natural host of the novel coronavirus . Pangolins (Li et al., 2020c) , snakes (Ji et al., 2020) , mink and turtles (C. picta bellii, C. mydas, and P. sinensis) are all potentially considered as intermediate hosts.

to angiotensin-converting enzyme-2 (ACE2) Li et al., 2003; , reducing the level of ACE2 and the production of active peptide angiotensin-(1-7) [Ang-(1-7)] in the lung and the whole body to induce lung injury and multiple organ damage, which are attributed to the possible pathological mechanisms such as inflammation, oxidative stress and apoptosis. Since there are not yet any vaccines or drugs approved to fight against SARS-CoV-2, the Chinese government has decided to apply complementary and alternative medicine to treat COVID-19 by using TCM, which functions effectively in organ protection via anti-inflammation, antioxidant and anti-apoptotic actions Liu et al., 2018a; Yang et al., 2019a) . Preliminary clinical studies showed the beneficial effects of TCM decoction on COVID-19 (Ling, 2020) as indicated by the shortening of hospitalization duration and the reduction in the number of mild and moderate cases developed into severe ones .

A study has shown that serious complications are more likely to occur in COVID-19 patients who simultaneously suffer from other chronic diseases (Cao et al., 2020) . The high incidence of acute organ injury closely contributed to the increased mortality rate (Cao et al., 2020; Wang et al., 2020a) . Inflammatory storm, oxidative stress, and apoptosis are important hallmarks of the transition of COVID-19 patients from mild to severe or even critical periods, and these mechanisms greatly increase the risk of organ damage, especially for patients with chronic diseases (Qin et al., 2020) . Therefore, this review will discuss the protective effect of TCM recommended in China on viscera from the perspectives of inflammatory storm, oxidative stress and apoptosis.

Monoclonal antibodies, interferon therapies, and small molecule drugs are commonly used in Western medicine to combat HIV, HBV, and MERS (Li and Clercq, 2020) , but the long-term usage of these drugs is often accompanied by low selectivity and adverse side effects. A report recently published in The Lancet demonstrated no significant clinical improvement in severe COVID-19 patients treated with remdesivir as compared with the placebo-controlled group, indicating the limitation of the application alone with western medicine . The Chinese National Health Commision has figured out an essential strategy, a combination of TCM and Western medicine, to combat COVID-19, and successively published seriate versions of the diagnosis and treatment protocol. This section will start with the latest version (Trial Version 7) of the Diagnosis and Treatment Protocol for COVID-19 (in short "the Protocol") (National Health Commission of the People's Republic of China, 2020), and introduce TCM formulas and Chinese patent medicine recommended for each developing stage of COVID-19 in the Protocol (Table 1) . COVID-19 can be roughly divided into three stages, the medical observation stage, the clinical treatment stage and the stage of convalescence. The treatment stage is further subdivided into mild, moderate, severe and critical based on the severity of the disease.

In the medical observation stage, patent Chinese medicine such as Huoxiang Zhengqi capsules (symptom with fatigue and gastrointestinal upset) or Lianhua Qingwen capsules (symptom with fever and weakness) are administered to suspected COVID-19 patients.

In the clinical medication stage, patients of mild COVID-19 often have mild fever and respiratory symptoms. The recommended decoction mainly includes single Chinese herb such as Magnolia officinalis, Scutellaria baicalensis, and licorice.

Patients of moderate COVID-19 with mild fever and exacerbated respiratory symptoms are recommended to be prescribed with medicine such as licorice, Magnolia officinalis and Atractylodes rhizome. Patients of severe COVID-19 with respiratory symptoms manifested as respiratory distress are recommended to take TCM and herbal decoction including Rheum officinale, Salvia miltiorrhiza, Astragalus membranaceus, Lonicera japonica Thunb, Magnolia officinalis, and licorice. For the critically ill patients who are characterized by respiratory failure, auxiliary ventilation is required. At this stage, the joint use of TCM decoction and patent Chinese medicine will achieve better therapeutic efficacy (National Health Commission of the People's Republic of China, 2020).

In accordance with the clinical observations of doctors in various locations, the Qingfei Paidu decoction recommended by the Protocol is applicable to mild, moderate and severe cases, and could also be used in critically ill patients in consideration with their actual conditions. Qingfei Paidu decoction is a combination of Chinese prescriptions that include Maxing Shigan decoction, Shegan Mahuang decoction, Xiao Chaihu decoction, and Wuling powder. Its broad application in different stages of COVID-19 stems not only from the combination of various Chinese prescriptions, but also from its acting on multiple potential targets through distinct intervention pathways. Patients who had repeated fever and cough with obscure respiratory rales of both lungs before receiving this treatment had their body temperature returned to normal on the night of the administration of Qingfei Paidu decoction and chest CT scan showed improvement after 6 days of treatment . The total effective rate for confirmed COVID-19 patients using this prescription in the 4 pilot provinces of China is over 90% by February 6, 2020 (National Administration of Traditional Chinese Medicine, 2020).

Convalescence is a period when a patient has just recovered from illness and is property, such as Lonicera japonica Thunb, Scutellaria baicalensis, Astragalus membranaceus, and Salvia miltiorrhiza (Chen et al., 2020b) . The underlying antiviral mechanisms can be roughly divided into the following two: (1) direct inhibition of viruses. Based on TCM principles, most of the herbs exert heat-clearing and detoxifying properties, such as Lonicera japonica Thunb and Scutellaria baicalensis;

(2) indirect antiviral effect or inhibition of virus-mediated inflammatory response via modulating immune function, such as Astragalus membranaceus and Salvia miltiorrhiza. However, the use of antiviral herbal medicine only could not effectively prevent tissue injuries due to inflammatory storm, oxidative stress or apoptosis caused by excessive immune response associated with COVID-19. Thereafter, we will discuss the protective effects of TCM on organ damages from the anti-inflammatory, antioxidant and anti-apoptosis perspectives.

TCM theory demonstrates that traditional herbal medicine pays special attention to the overall regulation of the body and the differentiation of clinical syndromes (Fan et al., 2020) . The decision which particular TCM formula and/or Chinese patent medicine is to be used is based on the specific Chinese medicine syndrome associated with disease. Therefore, compared with the use of single TCM compound, TCM formula and Chinese patent medicine are more widely applied in fighting against this epidemic as combination of multiple herbs could not only cure diseases but also correct Chinese medicine syndromes through acting on multiple targets via diverse regulation pathways.

It will take a long time to develop vaccines and specific medicines targeting SARA-CoV-2. At the present stage, TCM intervention could elevate COVID-19 recovery rate with no adverse side effects. The Chinese government has actively encouraged the application of TCM in fighting against the epidemic (Zhang et al., 2020a) .

The inhibition of lymphocytes by TCM in severe COVID-19 patients was shown by the lowered CD4 + T and CD8 + T, both of which are closely associated with the inflammation (Wan et al., 2020) . Patients infected with SARS-CoV-2 had higher concentrations of IL-1β, IL-7, IL-8, IFN-γ, IP10, and MCP1 than those in healthy adults. Moreover, severe COVID-19 patients showed higher circulating levels of GCSF, IP10, MCP1, MIP1A, and TNF-α, suggesting that cytokine storm had occurred during the development of COVID-19 . Inflammation associated with cytokine storm begins at a local site and spreads to the whole body via the systemic circulation (Medzhitov, 2008) .

According to the Protocol, Chinese herbs with anti-inflammatory activity such as Rheum officinale, Scutellaria baicalensis, patchouli, ginseng, Salvia miltiorrhiza, and gypsum, are clinically applied to treat COVID-19 ( Table 2 Moreover, baicalein was able to suppress the over-production of inflammatory cytokines, including NO, PGE2, TNF-α, and IL-6, in an intervertebral disc degeneration model (Jin et al., 2019) . In addition, ginsenoside Rf, one of the active saponins found in ginseng, significantly decreased the level of IL-1β, IL-6 and TNF-α in an incisional pain model . Furthermore, tanshinone IIA (Tan IIA), a well-known flavonoid ingredient of Salvia miltiorrhiza, elicited an important therapeutic effect by inhibiting inflammatory response (Zheng et al., 2014 ). An early study indicated that Tan IIA exerted anti-inflammatory effect by deactivating TLR4-MyD88-NF-κB signaling pathway and regulating production of series of cytokines such as TNF-α, IL-1β and COX-2 in LPS-induced RAW264.7 cells (Fan et al., 2016) .

The balance between oxidation and antioxidation plays an important role in the regulation of signal transduction, cell proliferation and apoptosis (Forrester et al., 2018) . When the balance is destroyed by stress, virus or other factors, oxidative stress response will be stimulated (Forrester et al., 2018) . The excessive immune response associated with COVID-19 might largely promote the production of free radicals, consequently the over-accumulation of oxidative free radicals, leading to tissue injury and organ damage. The Protocol recommends the application of kinds of traditional Chinese herbs to inhibit oxidative stress stimulated by SARS-CoV-2 as many herbs such as Codonopsis pilosula, Glycyrrhiza glabra roots, Astragalus membranaceus, Lonicera japonica Thunb, and Forsythiae Fructus contain naturally-occurring bioactive components that exert anti-oxidative effects (National Health Commission of the People's Republic of China, 2020).

Astragaloside IV (AS-IV), an active compound from Astragalus membranaceus, pharmacologically displays anti-oxidative stress effects (Qiu et al., 2010) . A research study found that AS-IV (20 mg/kg) effectively attenuated the expression of 8-hydroxy-2'-deoxyguanosine (8-OHdG) (a maker of oxidative damage in intact DNA) in both glomeruli and tubules, decreased the malondialdehyde (MDA) level and enhanced the superoxide dismutase (SOD) activity associated with indoxyl sulfate-induced tubulointerstitial injury , as well as displayed therapeutic potential in prevention of dementia caused by cerebral hypoperfusion, suggesting that the ameliorating effect of AS-IV on learning and memory deficits might be attributed to its suppressive effect on neuronal apoptosis and oxidative damage in the hippocampus (Kim et al., 2015) . Furthermore, pretreatment with Tan IIA induced the nuclear accumulation of Nrf2 and triggered the expression of its downstream gene heme oxygenase-1 (HO-1) and NADPH dehydrogenase quinone-1 (NQO-1) in both mice cardiac tissue and H9c2 cells (Guo et al., 2018) . Nrf2/HO-1 signaling was also affected by the water extract of Forsythiae Fructus which suppressed inflammation and disrupted inflammatory signaling cascade (Lee et al., 2018) . Baicalin protected against LPS-induced severe lung injury by activating an antioxidant system and reducing both the number of inflammatory cells and expression of mediators via the Nrf2/HO-1 signaling pathway (Meng et al., 2019) . Moreover, it exerted beneficial effect on lung function as shown by anti-airway remodeling through regulating the release of proinflammatory cytokine in long-term cigarette smoke-induced chronic obstructive pulmonary disease model (Wang et al., 2018) . Neochlorogenic acid isolated from LJT, an activator of AMPK/Nrf2 signaling, prevented excessive macrophage-mediated responses associated with acute and chronic inflammatory disorders (Park et al., 2018) . Thus, previous studies revealed that the Nrf2-mediated HO-1 signaling pathway might be a crucial antioxidant target. Collectively, activation of the antioxidant enzymes activity and Nrf2/HO-1 signaling pathway is potentially recognized as one of the anti-oxidant mechanisms involved in the treatment of COVID-19 using TCM.

A study on clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan (China) indicated that among the 710 patients with COVID-19, most patients had organ function damages, including 35 with acute respiratory distress syndrome (ARDS), 15 with acute kidney injury, 12 with cardiac injury, and 15 with liver dysfunction (Yang et al., 2020b) . Recently multiple lines of evidences pointed to the idea that renal impairment was common in COVID-19 patients, a condition that might lead to multi-organ failure and death eventually (Li et al., 2019b) . Studies have shown that the progression of various diseases such as ARDS, heart failure, chronic kidney disease and liver injury are closely related to apoptosis.

The apoptosis of pulmonary capillary endothelial cells and alveolar epithelial cells worsened the structural integrity and function of the alveolar-capillary barrier, and eventually resulted in pneumonia and ARDS (Hu, 2018) . Apoptosis was also in the pathogenesis of heart failure (Sabbah and Sharov, 1998) . Apoptosis of podocytes could lead to proteinuria and the development and progression of glomerulosclerosis and renal fibrosis (Cao et al., 2016; Chuang et al., 2011) . Liver injury was also associated with dysregulation of hepatocyte apoptosis (Wang, 2015) . Current research studies have found that 3 signaling pathways (Fig. 1) are involved in apoptosis, they are the exogenous apoptosis pathway induced by death receptors, endogenous apoptosis pathway mediated by mitochondria, and endoplasmic reticulum stress (Marriott et al., 2006; Zhao et al., 2013) .

Chinese regions after the spread of COVID-19, Astragalus membranaceus is recommended in 13 prevention programs with the aim to reinforce vital Qi.

Scutellaria baicalensis, Magnolia officinalis, Pseudo-ginseng, and Rhodiola crenulata are also usually used in different prescriptions .

It was found that Astragalus membranaceus and its active component (Astragalus polysaccharide, AP) and compound (AS-IV) could protect against multiple-organ damages induced by apoptosis. AP could inhibit mitochondrial-mediated apoptosis and reduce cell damage by mediating the PI3K/Akt/FoxO3a signaling pathway (Lu and Yang, 2017) ; it could also decrease hepatocytes apoptosis caused by oxidative stress (Liu, 2018b) . AS-IV dose-dependently inhibited the rise in apoptosis induced by oxidative stress in renal podocytes (Xiao et al., 2013) , and prevented human umbilical vein endothelial cell (HUVEC) apoptosis by inhibiting Nox4 expression through the Nox4/Smad2 pathway (H 2 O 2 -induced cell apoptosis) (Ma et al., 2015; . Baicalein protected cardiomyocytes by decreasing oxidative stress, myocardial inflammatory responses and apoptosis associated with LPS-induced sepsis (Lee et al., 2011) . It could also stabilize MARCH5 expression by upregulating expression of KLF4, and in a sequence promote mitochondrial fusion, stabilize mitophagy and reduce apoptosis, suggesting that baicalein could significantly attenuate apoptosis induced by oxidative damage (Li et al., 2020a) . Additionally, studies showed that triptriolide exerted its protective effect via inhibiting apoptosis and restoring of survivor, on podocytes with exposure to puromycin aminonucleoside, which could induce apoptosis by increasing protein expression of caspase-3 and Bax (Yang et al., 2019) . Magnolol, a purified single compound from Magnolia officinalis, showed anti-apoptotic effect by protecting the liver from warm ischemia-reperfusion injury through upregulation of mRNA expression of the anti-apoptotic factor Bcl-XL and suppression of gene expression of Bcl-Xs (Jawan et al., 2003) . Taken together, the active ingredients from TCM recommended in the Protocol could inhibit mitochondrial pathway-involved apoptosis.

AS-IV could suppress apoptotic and inflammatory responses in HUVECs upon to the stimulation with high glucose by inhibiting the JNK signaling pathway (You et al., 2019) . Xuesaitong (XST), a TCM pharmaceutic preparation consisting of total saponins from the root of Pseudo-ginseng, could effectively treat patients with cerebrovascular diseases by inhibiting the overload of Ca 2+ in brain cells, stabilizing cell membrane and protecting the brain from ischemia/reperfusion damage (Zhong et al., 2005) . XST attenuated ischemic stroke in mice through regulating microglial phenotypes and decreasing apoptosis of neuronal cells (Li et al., 2019a) . Moreover, treatment with XST ameliorated podocyte apoptosis in diabetic rats partly through modulation of PTEN-PDK1-Akt-mTOR pathway and Nox4 expression, which might point to a novel natural therapeutic way to cure diabetic nephropathy (Xue et al., 2020) . Thus, inhibition of endoplasmic reticulum stress is one of the mechanisms by which TCM exerts its anti-apoptosis actions.

Study indicated that aging induced by D-galactose could trigger marked neuronal apoptosis through activation of extrinsic-dependent apoptotic pathways. Intriguingly, Rhodiola crenulata protected against neurotoxicities which could stimulate the apoptotic pathways in aging brain (Chen et al., 2020a) . Furthermore, Rhodiola polysaccharide could reduce the apoptosis of bone marrow cells and promote the recovery of its hemopoietic function by affecting Fas/FasL-caspase-3 apoptosis signal pathway (Li et al., 2008a) , which was also involved in apoptosis associated with jaundice hepatitis. Rhubarb exerted its therapeutic efficacy in patients with jaundice hepatitis by regulating the Fas/FasL system (Huang et al., 2008) . Ligustrazine could repress Fas/FasL axis to inhibit hepatocyte apoptosis, consequently improving CCl 4 -induced liver fibrosis in rats (Li et al., 2008b) . Additionally, polysaccharide from lycium barbarum modulated the apoptosis of brain cells by inhibiting the expression of Fas; it also played a role in improving brain functional memory (Cai et al., 2005) . Therefore, traditional Chinese herbs and active components recommended in the Protocol could suppress apoptosis through mediating the death receptor pathway.

Since 2003, TCM has played a significant role in combating viruses such as SARS-CoV, MERS-CoV and Ebola virus (Chen and Nakamura, 2004) . TCM has received much attention due to its multi-component, multi-target properties, and multi-pharmacological effects. The National Health Commission of the People's Republic of China emphasized the concept of TCM and Western Integrative Medicine.

Various herbal formulas and active components of TCM have certain potential in treating COVID-19 via differential pharmacological mechanisms (Fig. 2) . Amount of evidences supported the therapeutic efficacy of TCM in improving the clinical symptoms of COVID-19, while, the underlying mechanisms behind the antiviral effects, especially in models infected with SARS-CoV-2, the immunomodulatory response in host cells, and the inhibitory effects on cytokine inflammatory storm, etc., remain elusive. Moreover, the screening for candidate naturally-occurring component from TCM should be further carried out and the novel compatibility with active components will be further developed based on the exploration of substance basis and the clarification of pharmacological mechanism. Importantly, multicenter studies with rigorous randomized controlled trials need to be performed to provide more clinical evidences of the clinical effectiveness of TCM. All data were generated in-house, and no paper mill was used. All authors agree to be accountable for all aspects of work ensuring integrity and accuracy. 

Caution on kidney dysfunctions of SARS-CoV-2 patients

The effect of lycium barbarum polysaccharideson protecting brain function of lead-exposed mice

Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy

Neuroprotective effect of Rhodiola crenulata in D-galactose-induced aging model

Application and research progress of traditional Chinese medicine in prevention and treatment of coronavirus disease 2019

Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS

Alteration of forkhead box O (Foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus

Therapeutic potentials of baicalin and its aglycone

Anti-inflammatory activity of tanshinone IIA in LPS-stimulated RAW264.7 macrophages via miRNAs and TLR4-NF-κB pathway

Research progress on immunomodulatory effect of Chinese materia medica and prescriptions on viral pneumonia

Reactive oxygen species in metabolic and inflammatory signaling

Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm

Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicininduced cardiotoxicity

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Effect of rhubarb on Fas/ FasL expression in patients with jaundice hepatitis

Study on the preventive effect of Chinese medicine fu su he ji on ARDS rats associated with sepsis

The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver

Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress

Cross-species transmission of the newly identified coronavirus 2019-nCoV

Baicalein inhibits the IL-1β-induced inflammatory response in nucleus pulposus cells and attenuates disc degeneration in vivo

Antinociceptive and anti-inflammatory effects of ginsenoside Rf in a rat model of incisional pain

Ameliorating the effect of astragaloside IV on learning and memory deficit after chronic cerebral hypoperfusion in rats

Anti-inflammatory activity of the decoction of Forsythia suspensa (Thunb.) Vahl is related to Nrf2 and A20

Baicalein, an active component of Scutellaria baicalensis Georgi, improves cardiac contractile function in endotoxaemic rats via induction of heme oxygenase-1and suppression of inflammatory responses

Xuesaitong may protect against ischemic stroke by modulating microglial phenotypes and inhibiting neuronal cell apoptosis via the STAT3 signaling pathway

Rhodiola polysaccharide: its effects on apoptosis related protein expression of rats with myelosuppression

Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules

Baicalein inhibits mitochondrial apoptosis induced by oxidative stress in cardiomyocytes by stabilizing MARCH5 expression

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

Effect of ligustrazine on expression of Fas/FasL in rats with hepatic fibrosis

Angiotensin-converting enzyme 2 is a functional receptor for the SARS Coronavirus

Research progress on the interactions among tissue renin-angiotensin system, vitamin D receptor and Wnt/β-catenin in chronic diseases

Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2

Balancing effect of biejiajian oral liquid on ACE-Ang II-AT1R axis and ACE2-Ang-(1-7)-Mas axis in rats with CCl4-induced hepatic fibrosis

Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)

The comparison of antioxidative and hepatoprotective activities of Codonopsis pilosula polysaccharide (CP) and sulfated CP

Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis

Protective effect of combination of Astragalus polysaccharides and Lycium barbarum polysaccharides on liver injury in mice

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2

Effect of astragalus polysaccharides on cell injury and mitochondrial pathway apoptosis in the hypoxia reoxygenation of myocardial cells

Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan

AST IV inhibits H2O2-induced human umbilical vein endothelial cell apoptosis by suppressing Nox4 expression through the TGF-β1/Smad2 pathway

Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia

Origin and physiological roles of inflammation

Baicalin ameliorates lipopolysaccharide-induced acute lung injury in mice by suppressing oxidative stress and inflammation via the activation of the Nrf2-mediated HO-1 signaling pathway

Progress has been made in the selection of effective prescriptions of traditional Chinese medicine

National Health Commission of the People's Republic of China, 2020. Diagnosis and Treatment Protocol for COVID-19

Neochlorogenic acid inhibits against LPS-activated inflammatory responses through up-regulation of Nrf2/HO-1 and involving AMPK pathway

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation

Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats

Real-time forecasts of the COVID-19 epidemic in China from

Apoptosis in heart failure

Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer

Clinical features and treatment of COVID-19 patients in northeast Chongqing

Antioxidant activities of aqueous extracts from 12 Chinese edible flowers in vitro and in vivo

Baicalin exerts anti-airway inflammation and anti-remodelling effects in severe stage rat model of chronic obstructive pulmonary disease

Molecular mechanisms of hepatic apoptosis regulated by nuclear factors

Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

World Health Organization, 2020a. WHO Director-General's opening remarks at the media briefing on COVID-19-28

World Health Organization, 2020b. WHO Director-General's remarks at the media briefing on

Emodin attenuates severe acute pancreatitis via antioxidant and anti-inflammatory activity

Effects of astragaloside IV protect against podocyte lesion exposed to high glucose

Emodin weakens liver inflammatory injury triggered by lipopolysaccharide through elevating microRNA-145 in vitro and in vivo

Analysis on prevention plan of corona virus disease-19 (COVID-19) by traditional Chinese medicine in various regions

Xuesaitong protects podocytes from apoptosis in diabetic rats through modulating PTEN-PDK1-Akt-mTOR pathway

Natural products against renin-angiotensin system for antifibrosis therapy

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Dual-function of triptriolide in podocytes injury: inhibiting of apoptosis and restoring of survival

Astragaloside IV prevents high glucoseinduced cell apoptosis and inflammatory reactions through inhibition of the JNK

In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

One highly suspected case of novel coronavirus pneumonia treated by Integrated Traditional Chinese and Western medicine and nucleic acid analysis

Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects

Death receptor pathway of cell apoptosis

Anti-inflammatory mechanism research of tanshinone IIA by module-based network analysis

Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction

Qingfei Paidu Decoction Damp-heat accumulation in the lung pattern Scutellaria baicalensis, Magnolia officinalis, etc. Moderate Damp-toxin constraint in the lung pattern Licorice, Semen lepidii, Ephedra herb

Severe Epidemic toxin blocking the lung pattern Licorice, Rheum officinale, etc. Blazing of both qi and ying pattern Salvia Miltiorrhiza, Coptis chinensis, etc. Critical Internal blockage and external desertion pattern Ginseng, Lonicera japonica Thunb, etc. Convalescence Lung-spleen qi deficiency pattern Codonopsis pilosula, Astragalus membranaceus, etc. Deficiency of both qi and yin pattern Salvia miltiorrhiza

This work was supported in part by Essential Drug Research and Development